Percheron Therapeutics Ltd
PER
Company Profile
Business description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Contact
35 Collins Street
Level 30, Collins Place
MelbourneVIC3000
AUST: +61 398278999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
8
Stocks News & Analysis
stocks
Are investors too bearish on Australian equities?
A new report suggests the pessimism might be overdone.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,178.90 | 5.00 | 0.05% |
| CAC 40 | 8,150.45 | 50.43 | -0.61% |
| DAX 40 | 24,127.94 | 3.73 | 0.02% |
| Dow JONES (US) | 47,904.07 | 272.07 | 0.57% |
| FTSE 100 | 9,750.41 | 5.73 | -0.06% |
| HKSE | 26,282.69 | 63.45 | -0.24% |
| NASDAQ | 23,736.62 | 221.85 | -0.93% |
| Nikkei 225 | 51,325.61 | 17.96 | 0.04% |
| NZX 50 Index | 13,459.29 | 50.08 | 0.37% |
| S&P 500 | 6,865.61 | 24.98 | -0.36% |
| S&P/ASX 200 | 8,885.50 | 5.50 | 0.06% |
| SSE Composite Index | 3,986.90 | 29.43 | -0.73% |